266 related articles for article (PubMed ID: 15664532)
1. Determinants of the eradicability of filarial infections: a conceptual approach.
Duerr HP; Dietz K; Eichner M
Trends Parasitol; 2005 Feb; 21(2):88-96. PubMed ID: 15664532
[TBL] [Abstract][Full Text] [Related]
2. New insights into the biology of filarial infections.
Specht S; Wanji S
J Helminthol; 2009 Jun; 83(2):199-202. PubMed ID: 19379544
[TBL] [Abstract][Full Text] [Related]
3. Lymphatic filariasis and Brugia timori: prospects for elimination.
Fischer P; Supali T; Maizels RM
Trends Parasitol; 2004 Aug; 20(8):351-5. PubMed ID: 15246315
[TBL] [Abstract][Full Text] [Related]
4. Vector transmission heterogeneity and the population dynamics and control of lymphatic filariasis.
Michael E; Gambhir M
Adv Exp Med Biol; 2010; 673():13-31. PubMed ID: 20632527
[TBL] [Abstract][Full Text] [Related]
5. High infection rates at low transmission potentials in West African onchocerciasis.
Duerr HP; Leary CC; Eichner M
Int J Parasitol; 2006 Nov; 36(13):1367-72. PubMed ID: 16979644
[TBL] [Abstract][Full Text] [Related]
6. Control of onchocerciasis.
Boatin BA; Richards FO
Adv Parasitol; 2006; 61():349-94. PubMed ID: 16735169
[TBL] [Abstract][Full Text] [Related]
7. The Current Status of Molecular Xenomonitoring for Lymphatic Filariasis and Onchocerciasis.
Pilotte N; Unnasch TR; Williams SA
Trends Parasitol; 2017 Oct; 33(10):788-798. PubMed ID: 28756911
[TBL] [Abstract][Full Text] [Related]
8. Mathematical models and lymphatic filariasis control: endpoints and optimal interventions.
Michael E; Malecela-Lazaro MN; Kabali C; Snow LC; Kazura JW
Trends Parasitol; 2006 May; 22(5):226-33. PubMed ID: 16564745
[TBL] [Abstract][Full Text] [Related]
9. Recrudescence of onchocerciasis in the Comoé valley in Southwest Burkina Faso.
Koala L; Nikiema A; Post RJ; Paré AB; Kafando CM; Drabo F; Traoré S
Acta Trop; 2017 Feb; 166():96-105. PubMed ID: 27845063
[TBL] [Abstract][Full Text] [Related]
10. [The campaign against onchocerciasis in Africa: update].
Boussinesq M; Hougard JM
Med Trop (Mars); 1998; 58(3):285-96. PubMed ID: 10088109
[TBL] [Abstract][Full Text] [Related]
11. Candidate parasitic diseases.
Behbehani K
Bull World Health Organ; 1998; 76 Suppl 2(Suppl 2):64-7. PubMed ID: 10063677
[TBL] [Abstract][Full Text] [Related]
12. Nigeria's war on terror: fighting dracunculiasis, onchocerciasis, lymphatic filariasis, and schistosomiasis at the grassroots.
Njepuome NA; Hopkins DR; Richards FO; Anagbogu IN; Pearce PO; Jibril MM; Okoronkwo C; Sofola OT; Withers PC; Ruiz-Tiben E; Miri ES; Eigege A; Emukah EC; Nwobi BC; Jiya JY
Am J Trop Med Hyg; 2009 May; 80(5):691-8. PubMed ID: 19407107
[TBL] [Abstract][Full Text] [Related]
13. Threshold of transmission of Brugia malayi by Anopheles sinensis.
Zhang SQ; Zhang QJ; Cheng F; Wang LL; Pen GP
J Trop Med Hyg; 1991 Aug; 94(4):245-50. PubMed ID: 1880826
[TBL] [Abstract][Full Text] [Related]
14. [ Bancroftian lymphatic filariasis: toward its elimination from the Pacific?].
Chanteau S; Roux JF
Bull Soc Pathol Exot; 2008 Jun; 101(3):254-60. PubMed ID: 18681220
[TBL] [Abstract][Full Text] [Related]
15. Filaria control and elimination: diagnostic, monitoring and surveillance needs.
Molyneux DH
Trans R Soc Trop Med Hyg; 2009 Apr; 103(4):338-41. PubMed ID: 19181357
[TBL] [Abstract][Full Text] [Related]
16. Complex ecological dynamics and eradicability of the vector borne macroparasitic disease, lymphatic filariasis.
Gambhir M; Michael E
PLoS One; 2008 Aug; 3(8):e2874. PubMed ID: 18716676
[TBL] [Abstract][Full Text] [Related]
17. Vectors of lymphatic filariasis of human.
Okulewicz A; Frońska-Popiel A
Wiad Parazytol; 1999; 45(4):535-6. PubMed ID: 16888997
[No Abstract] [Full Text] [Related]
18. Intervention research on onchocerciasis and lymphatic filariasis.
Wkly Epidemiol Rec; 2000 Jul; 75(30):246-8. PubMed ID: 10946596
[No Abstract] [Full Text] [Related]
19. Diagnostic tools for filariasis elimination programs.
Weil GJ; Ramzy RM
Trends Parasitol; 2007 Feb; 23(2):78-82. PubMed ID: 17174604
[TBL] [Abstract][Full Text] [Related]
20. Onchocerciasis: a review of clinical, pathologic and chemotherapeutic aspects, and vector control program.
Gibson DW; Duke BO; Connor DH
Prog Clin Parasitol; 1989; 1():57-103. PubMed ID: 2491695
[No Abstract] [Full Text] [Related]
[Next] [New Search]
